The association of these breast cancer subtypes with response appears to be mediated, at least in part, by higher HER2 amplification and decreased HR expression in the HER2-enriched and IC5 subgroups, consistent with another report that intrinsic subtype was no longer associated with pCR when ESR1 and ERBB2 expression were included in a multivariate analysis27. The gene discussed is ERBB2; the disease is breast carcinoma.